Liver cancer prognosis model based on three blood test indexes

• Main Authors: FAN JIA, HUANG AO, GUO DEZHEN, ZHOU JIAN, WANG YUPENG
• Format: Patent
• Language: Chinese; English
• Published: 26.08.2022
• Subjects: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA; INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS; PHYSICS

The invention relates to a liver cancer prognosis model based on three blood test indexes, and belongs to the technical field of biological medicines. The method comprises the following steps: detecting blood test indexes of C reactive protein (CRP), aspartate aminotransferase AST and an absolute value L of lymphocyte; calculating scores according to a model formula; the model formula is as follows: risk score = CRP * AST/L; if the risk score is greater than 80, the patient is a high-risk patient. According to the invention, the total survival time and disease-free survival time of the liver cancer patient after operation can be predicted only by detecting blood test indexes of C-reactive protein (CRP), aspartate aminotransferase AST and an absolute value L of lymphocyte. The method is simple and convenient to operate, effective and reliable, and can be used as a reference for formulating a further optimized monitoring and intervention strategy for a patient; and the post-operation reexamination cost of the p